Effects of pemafibrate (a selective PPAR-¿ agonist) versus weight loss through an intensive lifestyle modification on liver enzymes, serum soluble dipeptidyl peptidase-4, and hepatic steatosis and fibrosis evaluated by FibroScan transient elastography in people with type 2 diabetes and MASLD Kanako Kato; Teruo Jojima; Dai Tanuma; Kanako Suda; Shintaro Sakurai; Toshie Iijima; Takuya Tomaru; Isao Usui; Yoshimasa Aso;

New evidence for the effect of type 2 diabetes and glycemic traits on lung function: a Mendelian randomization and mediation analysis Shuo Xie; Liping Yu; Lulu Song; Fei Chen; Wanlu Ma; Yifan He; Xiaoping Chen; Ying Yang; Bo Zhang;

Identification of differentially expressed genes, pathways, and immune infiltration in diabetes Ying Liang; ShuXiang Wei; Xing Peng; QiLing Feng; LingLing Li; DieFei Liang; HongShi Wu; XiaoYun Zhang; ChuLin Huang; YongQing Lin;